(S)-Lercanidipine D3 Hydrochloride
| Product Name | (S)-Lercanidipine D3 Hydrochloride |
|---|---|
| Alternate Names | Lercanidipine Stable Isotopes, Stable Isotopes of Lercanidipine |
| CAT No. | CS-O-06714 |
| CAS No. | 1217740-02-7 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 651.21 g/mol |
| Mol. For. | C₃₆H₃₉D₃ClN₃O₆ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Lercanidipine |
| Purity | 95% |
| Therapeutic | Anti-Hypertensives |
| Smileys | O=C(C([C@@H](C1=CC([N](=O)=O)=CC=C1)C(C(OC)=O)=C(C)N2)=C2C)OC(C)(C)CN(C([2H])([2H])[2H])CCC(C3=CC=CC=C3)C4=CC=CC=C4.Cl |
| Canonical Smiles | CC1=C(C(C(=C(N1)C)C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC.Cl |
| InchIKey | WMFYOYKPJLRMJI-RFTUCFSWSA-N |
| Inchl | InChI=1S/C36H41N3O6.ClH/c1-24-31(34(40)44-6)33(28-18-13-19-29(22-28)39(42)43)32(25(2)37-24)35(41)45-36(3,4)23-38(5)21-20-30(26-14-9-7-10-15-26)27-16-11-8-12-17-27;/h7-19,22,30,33,37H,20-21,23H2,1-6H3;1H/t33-;/m0./s1/i5D3; |
| IUPAC | 5-O-[1-[3,3-diphenylpropyl(trideuteriomethyl)amino]-2-methylpropan-2-yl] 3-O-methyl (4S)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
(S)-Lercanidipine D3 Hydrochloride is a chemical compound that belongs to the dihydropyridine class of calcium channel blockers. It is a deuterated form of (S)-Lercanidipine Hydrochloride, which is used for the treatment of hypertension and angina pectoris. It is a white or off-white crystalline powder that is soluble in water and ethanol.
The mechanism of action of (S)-Lercanidipine D3 Hydrochloride involves the blockade of L-type calcium channels in the smooth muscle cells of blood vessels, causing vasodilation and lowering of blood pressure. The deuterated form of the drug is often used in pharmacokinetic studies to determine the bioavailability and metabolism of the drug in humans.
The recommended dosage of (S)-Lercanidipine D3 Hydrochloride is 10 mg to 20 mg once daily, with a maximum dose of 20 mg per day. It is usually administered orally, and its effects can last for up to 24 hours.
There are several precautions and contraindications associated with the use of (S)-Lercanidipine D3 Hydrochloride. Patients with severe liver or kidney dysfunction, hypotension, or a history of allergic reactions to dihydropyridines should avoid taking the drug. It may also interact with other medications, such as beta-blockers and digoxin.
In conclusion, (S)-Lercanidipine D3 Hydrochloride is a potent calcium channel blocker that is used for the treatment of hypertension and angina pectoris. Its deuterated form is often used in pharmacokinetic studies, and it should be used with caution in patients with certain medical conditions or who are taking other medications.
Get an Instant Quote
Related Compounds
R(-)-Lercanidipine D3 Hydrochloride | Lercanidipine 13C D3 Hydrochloride | Lercanidipine D3 Hydrochloride |